KIELTYKA GLADKOWSKI is proud to be selected as one of most desired employers among law firms in Poland, according to one of the international students organisations.
The results in a legal organization always result from the full commitment of the entire team, whose potential must always be a balance between many years of experience and the energy and new ideas of young lawyers who spare no effort in acquiring practical skills, which is an integral complement to education and theoretical university knowledge.
Transferring practical knowledge and sharing experience with the next generation of lawyers in Poland is the natural goal and mission of KIEŁTYKA GŁADKOWSKI’s presence in the international legal environment. We are proud and honoured of the fact that our law firm is listed at the forefront of anonymous student rankings, completely independent of any public or professional organizations or institutions.
Our law firm is noticed not only on the domestic exchange of “desirable” places for gaining practical education.
Only recently, one of the students from Western Europe joined our team as part of the ERASMUS program.
The Polish National Fund for Environmental Protection and Water Management has announced another call for applications for co-financing under the priority program Energia Plus. Entrepreneurs can apply for co-financing, e.g. to renewable energy sources.
The goal of the Energia Plus program is to reduce the negative impact of enterprises on the environment by supporting investment projects. The budget allocated to support investments in the fourth call for proposals has just been announced and amounts to PLN 566.9 million.
Patent protection for a newly introduced drug on the market lasts almost 20 years. During this time, no other company (except the one with the patent) has the right to produce it. When protection ends, the drug may be manufactured by other manufacturers who begin to compete with each other – such competing drugs are called generics.
The original and generic medicine may differ in name, manufacturer and price. However, the active substance contained in them, which is responsible for the action of the drug, and its amount will always be the same. Thanks to the guarantee of equally high production standards and constant monitoring of safety and effectiveness, patients can freely choose the product that best suits them in the pharmacy. The manufacturing process of generic drugs must follow the principles of Good Manufacturing Practice (GMP). Compliance with the GMP rules allows for the provision of good quality medical devices.
KIELTYKA GLADKOWSKI KG LEGAL takes part in the project “Systemic Design and Sustainable Healthcare for MedTech Manufacturing (SysteMA)”. One of elements of the project is led by the Life Science Cluster in Krakow and the MedSilesia cluster. The latter became involved in activities to raise awareness and knowledge in the field of the circular economy.
The research is part of the EIT Manufacturing project SysteMA (Systemic Design and Sustainable Healthcare for MedTech Manufacturing), which focuses on the role of MedTech manufacturing towards the environmental, social, and economic sustainability of healthcare systems. The project aims to create online training courses on this topic, providing EU companies with actionable skills to improve the sustainability of their products and processes and seize new market opportunities.
